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Organisational Impact of V150 Nurse Prescribing Qualification 
Abstract 
Nineteen V150 prescribers from eight professional roles, and prescribing for a variety of 
conditions, along with three Non-Medical Prescribing (NMP) Leads, participated in this 
evaluation. An initial literature search identified a deficit in the NMP evidence base in relation 
to V150 Community Practitioner Nurse Prescribing.  
The evaluation used a mixed methodology of questionnaires and telephone interviews. 
Nineteen V150 prescribers participated, with all of them completing the online questionnaire. 
Two of these also consented to a follow-up telephone interview. Three NMP Leads completed 
the online questionnaire. 
The findings suggested a benefit to the wider health organisation with regard to reduced 
attendance at Walk-in Centres, GP practices and A&E.  It is anticipated that the findings from 
this study may be prove useful to NMP Leads, NMP groups and commissioners as well as 
V150 prescribers. 
 
Key words: V150, prescribing, evaluation, nurse prescribing 
 
Introduction 
This paper presents findings from an evaluation of V150 prescribing, commissioned by Health 
Education England North West. The purpose of the study was to examine NMP Leads’ and 
V150 prescribers’ perceptions of the impact of V150 prescribing on V150 prescribers, patients 
and organisations.  
There is little reference to V150 prescribing in the current non-medical prescribing (NMP) 
evidence base. Much of the current NMP research uses a quantitative approach. As such, it 
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does not address the V150 nurse prescribers’ experiences and perception. This study seeks 
to address these gaps in knowledge by collecting data from and specific to, V150 Community 
Practitioner Prescribers, practising in NHS Trusts across the North West of England. 
 
The NMP Context 
A broad literature search on non-medical prescribing was undertaken after a refined search 
using the search term “V150” yielded no results. The literature provided information on the 
wider NMP context within which V150 prescribing sits. 
A recent study undertaken by i5 Health, on behalf of NHS Health Education North West, 
identified a range of organisational benefits resulting from non-medical prescribing within the 
UK. Their report, titled “Non-Medical Prescribing: An Economic Evaluation” (NHS Health 
Education North West, 2015), identified how having a NMP practitioner within a practice 
setting can result in substantial cost savings. Earlier studies identified how the positive impact 
of NMP had realised the prediction of the Cumberlege Report by achieving high levels of 
satisfaction and trust from service users (Cox & Walton, 1998; Courtenay & Carey, 2005; 
Ersser, 2011).  
Although the evidence base presents a benefit to organisations and individuals alike, there is 
evidence of inconsistency in the uptake of NMP training (Courtenay, 2013). One explanation 
for this is presented in a number of other studies which identify a range of organisational 
barriers to NMP, which include variations in the quality of supervision and mentorship as well 
as access to continuing professional development opportunities (Humphries & Green, 2000; 
Cooper, Anderson, Avery, Bissell, Guillaume, Hutchinson, Lymn, Murphy, Ratcliffe and Ward; 
2008).  
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Aims: 
 To investigate V150 prescribing activity in the North West region of England  
 To identify the impact of V150 prescribing on NHS organisations 
 To gather qualitative data on the V150 prescribers’ experience 
 To gain an understanding of the NMP Lead’s role in relation to V150 prescribing  
 
Study Design 
Method: 
The initial study proposal identified focus groups as the method for data collection. However, 
it proved difficult to recruit adequate numbers of participants to make this viable. It was thought 
most likely, based on feedback from practitioners, that this was due to work-based pressures 
limiting the time available to potential participants to attend.  
In response, approval via the research change process was sought, to enable a mixed 
methods approach, using questionnaires and telephone interviews. A questionnaire for the 
V150 prescribers, including three key questions focussing on V150 prescribing activity and 
two questions focussing on the range of products and conditions for which V150 prescribers 
prescribe and resources to support prescribing, was developed. Participants who completed 
the questionnaire were invited to participate in a follow-up interview via telephone, using the 
same questions. A second questionnaire was developed for the NMP Leads, with questions 
focussing on their perceptions of the impact of V150 on the organisation and ways in which 
the impact could be improved. 
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Ethical considerations 
University and NHS research committee ethical approval was obtained for the study. 
Participants who agreed to be interviewed were asked to give written consent prior to their 
interview, using a consent form sent to them by email. It was made clear to participants both 
verbally and through the consent form that they could withdraw from the research project at 
any point. 
 
Inclusion criteria:  
Participation in the research project was dependent on practitioners within participating Trusts 
holding a V150 prescribing qualification.  All participants worked in NHS settings across the 
North West of England.  
 
Data Collection: 
Data was gathered in the form of questionnaires, which were distributed, along with a 
participant information leaflet, by the Trusts’ NMP Leads to all V150 prescribers within ten 
North West NHS Trusts. An advantage of questionnaires is that they can be distributed to 
large numbers (Bell, 2014); although a disadvantage is the inability to probe deeper into 
answers that participants have written (Streubert and Carpenter, 2011). 
 
The V150 prescribing practitioners who participated represented four Trusts. No responses 
were received from the other six Trusts. Nineteen practitioners completed online 
questionnaires and two of these consented to telephone interviews. The quantitative and 
qualitative data collected was transcribed and analysed. A thematic analysis process was 
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followed, using the method introduced by Brown and Clarke (2014), exploring themes and 
patterns that emerged from the data and these are reported on in the results section.  
 
Results 
Impact of V150 Nurse Prescribing on the organisation: 
Out of the nurse prescribers who provided information, fifteen respondents identified their 
prescribing qualification and activities as having a positive impact on the wider Trust – see 
Fig.1 below.   
 
 
i. Impact of V150 nurse prescribing on G.P. services and hospital admissions: 
Comments from prescribers imply a cost saving benefit to other members of the multi-
disciplinary team e.g. GP, in both appointments and time. A participant stated, “Prescribed 
treatment… can start sooner rather than waiting for a GP to complete a prescription” 
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Fig 1: Does your V150 prescribing role have a positive 
impact on Trust business? Rate this from 1 (little positive 
impact) to 5 (very positive impact)
Source: Smith, Coucill and Nuttall (2017)
Total number of participants: 19 
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Another participant reported, “It means quicker access to items needed especially if it is near 
the weekend.  Patients can access the prescription item quickly and do not have to wait over 
the weekend for a prescription from the GP”  
This speed of treatment has the potential to save the NHS money as patients are assessed 
and treated in a timely manner. Fast treatment may negate a deterioration in condition and 
any extra costs this may have incurred. 
“If I did not prescribe, the GP would have to issue prescriptions every time.  We have expertise 
in the field – managing the condition well prevents patients getting infections – additional 
swelling – and keeps people in work/mobile/well.” This implies nurse prescribing can 
contribute positively to a working economy. 
There was also comment on the benefits of continuity of care “Prevents patients from having 
to go to practice nurse and prevents GP appointments.” Improved continuity can also be 
achieved: “Reduces GP time as if we are completing prescriptions, it means they don’t have 
to complete them. More continuity of care as we review our own treatment.” 
 
ii. Impact of V150 nurse prescribing on A&E, Walk-in Centres and hospital admissions: 
There is an inference that prescribing can reduce hospital admissions through the ability of 
nurse prescribers to deliver holistic, timely and preventative treatment. “It’s more cost-effective 
to have [V150] prescribers.  They can avoid patients going into hospitals, particularly if 
infections are spotted earlier…” 
Along with a reduced demand on time from the wider NHS team, “It saves multiple 
practitioners having to assess patients in order to get a prescription.” Also “Prevents patients 
from having to go to A&E or Walk-in Centre”  
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With limited resources and long waiting times in A&E and Walk-in Centres reported, nurse 
prescribing potentially could increase capacity within the NHS along with patient satisfaction 
due to reduced waiting times for treatment. 
 
iii. Impact of V150 nurse prescribing on patients / clients and time saved: 
All respondents reported a positive response from patients and carers with regard to their 
ability to prescribe. Time saved for families is highlighted in these nurse prescriber’s 
comments: 
 “When a patient receives a prescription during a visit they have the reassurance that this 
element of their care has been completed” and “Patients are able to take their prescription at 
their convenience and it offers a more efficient approach to care” 
This time saved for families can be perceived as precious time: 
“[patients] love it, particularly palliative patients – if they need products, there are issues 
already going on for that family, so they don’t want the issue of trying to get in touch with the 
GP, trying to get a prescription from the GP… if we’re there and we can do it alleviates some 
of the issues when they are already having a difficult time.”  
 
iv. Impact of local policy on V150 nurse prescribing activity: 
Local decision-making has an impact on nurse prescribing, for example, one of the Trusts who 
participated in the research study, have recently adopted a new policy with regard to supply 
of dressings.   
Dressings previously prescribed individually are now being stored in GP surgeries then 
practitioners take them directly to the patient:  “GPs have stopped prescribing dressings at 
present and as a result we are keeping a stock of dressings at the base to take to patients 
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prior to the visit.  I can still prescribe if it is an item not stocked, or if I need continence or skin 
care products.”  
One respondent suggested that this reduces nurse-prescribing capacity “I think with this new 
dressing’s initiative people are prescribing less.  I think we are using it less, which then has 
the issue that we are losing some of that confidence in your ability to prescribe.  So I don’t 
think that is helping prescribers who are actually prescribing less.” This suggests local policy 
decisions may have wider impacts on prescribing. 
Non-Medical Prescribing (NMP) Leads’ findings: 
NMP Leads from ten different Trusts received a questionnaire, from which three responded. 
Two of the three were from a nurse background holding prescribing qualifications, and one 
from a pharmacy background with no prescribing qualification. In total, the NMP leads who 
responded oversee three hundred and three V150 nurse prescribers. 
i. NMP Leads’ contact with V150 prescribers: 
The NMP leads commented about the type of contact they had with V150 prescribers: one 
had “lots of contact for information, governance, databases, applications and prescribing 
issues” another had contact through “email prescribing data, cascade relevant medicines 
information and answer queries, viable at nursing bases.” Another of the Leads meets face to 
face with prescribers regularly “on first qualification…..we have quarterly District Nurse NMP 
meeting…. We have a DN NMP group email… a random sample of 15% of all prescribers 
submit for peer review.” 
ii. Impact of V150 prescribing on Trust business: 
In response to the impact on Trust business, two NMP Leads reported a high impact from 
V150 nurse prescribing. A comment from one NMP Lead mirrors what the practitioners 
reported “enables practitioners to complete episodes of care. Save GP’s time. Experts in the 
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field are prescribing more appropriately therefore cost effective” These comments reflect the 
cost and time saving themes reported by V150 prescribers. 
When asked about the resources available to support the NMP Leads’ role, the two NMP 
Leads who have a prescribing qualification included peer and technical support “Trust leads 
Network, One to Ones, Regional Lead Network …. Senior Management Technician, 
administration support, IT and communications support to keep NMP intranet page updated.”  
The NMP Lead from a pharmacy background not holding a prescribing qualification did not 
mention these resources, reporting, “As a pharmacist I can access most medicines resources 
directly and provide support and advice to NMP’s in a timely manner. I also have access to 
prescribing data”. 
iii. Maximizing the use of V150 prescribers in the organisation: 
The final area on which NMP Leads commented, was regarding what would maximise the use 
of a V150 qualification in their organisation. Each NMP Lead answered this question 
differently, including one with only one word “funding”. Another NMP Lead cited “CPD for 
qualified leads e.g. medico-legal updates, prescribing influences, and wound care updates”  
The remaining NMP Lead from a pharmacy background highlighted historical, financial and 
educational influences that appear to suggest a reduction in the benefits of the V150 nurse 
prescribing qualification. “The majority of prescribing historically is for wound management 
products” (this is not reflected in the V150 prescribers’ findings). They go onto state “however 
local CCGs are now choosing to switch to Total Wound Purchase schemes which negate the 
need for FP10 prescriptions”. A financial justification for the V150 qualification being less 
useful is then given  “Also the NHS consultation on the use of items that can be purchased 
over the counter (OTC) may signify that a lot of products in the NPF become un-prescribable 
as patients will be expected to pay for them.” Finally, an educational perspective is given, “I 
am aware that fewer universities are providing V150 courses, which I suspect is questioning 
this level of nurse prescribing in the future”. 
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There is caution about generalizing the findings as only three NMP Leads participated, 
making this a very small sample. 
Conclusions  
The research did identify some impact of V150 prescribing on the wider NHS services and 
organisations. Cost and time benefits identified by V150 prescribers included a reduction in 
time and appointments with GPs, in reduced hospital admissions and in less A&E and Walk-
in Centre attendance.  V150 prescribers also reported treatment being able to start sooner, 
leading to a reduction in complications and infections and keeping people mobile and working. 
Benefits of V150 prescribing qualification, reported by prescribers in the research included: 
holistic appropriate care delivered in a timely manner with time saving benefits to patients and 
practitioners. 
 
 
 
 
 
 
 
 
 
 
Figure 2: Organisational impact of V150 qualification   
Practitioner 
 
 
V150 
QUALIFICATION 
Impact of V150 on GP services 
Fewer GP appointments, saving 
time and resources. 
Impact of V150 to patients and relatives: 
Holistic, timely assessment and treatment, 
potential reduction in infections, out of 
hours access, reduction in appointments. 
Impact of V150 on wider NHS organisations: 
Fewer A&E/Walk-in Centre attendances, 
fewer hospital admissions.  
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Potential bias: 
Except for one practitioner, only active V150 prescribers completed the questionnaires. 
Inclusion of V150 prescribers who did not use their prescribing qualification may have provided 
a clearer picture of V150 prescribing. It was recognised that as two of the researchers 
collecting and analysing the data was a lecturer in Non-Medical Prescribing, there may have 
been unconscious bias. To reduce the potential bias, a second researcher was selected who 
had no involvement in the prescribing programmes. 
 
Limitations 
Originally, it was proposed that focus groups would be used as it was expected that these 
would enable a richer data set to be gathered than would be possible by using online 
questionnaires. However, viability issues resulting from low numbers meant that this approach 
could not be used. An additional limitation related to the focus of the study being solely on the 
North West of England.  The lack of inclusion of inactive V150 prescribers also placed 
limitations on the findings.   
 
Recommendations 
There are implications for policy and practice.  Recent consultation around the inclusion of 
prescribing related content in pre-registration nursing education programmes and a V150 
“type” of prescribing qualification for newly qualified nurses, has the potential to exponentially 
increase the cost and time benefits for organisations. Vastly increasing the number of NMP 
prescribers in practice will have implications for support and resources in practice, largely for 
the NMP Leads and this will need consideration.  
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Suggestions for further research include targeting inactive V150 prescribers to identify the 
reasons for inactivity, and further exploration of the impact of policy such as stock dressings 
in primary care settings would also be useful. 
The research findings could be useful to prescribing practitioners, commissioners, NMP Leads 
and members of the multi-disciplinary prescribing team such as GPs and pharmacists.  
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